COMMUNIQUÉS West-GlobeNewswire

-
Achieve Life Sciences Announces Changes in Executive Leadership and Board of Directors
26/08/2024 -
Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)
26/08/2024 -
Structure Therapeutics Announces Participation in Upcoming Investor Conferences
26/08/2024 -
Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal Administration of Bel-sar for the First-Line Treatment of Patients with Early-Stage Choroidal Melanoma at The Retina Society Annual Meeting
26/08/2024 -
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
26/08/2024 -
IO Biotech Announces Participation in Upcoming Investor Conferences
26/08/2024 -
LifeMD to Participate in Three Investor Conferences During September
26/08/2024 -
Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer
26/08/2024 -
Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference
26/08/2024 -
Notable Labs Announces CEO Transition
26/08/2024 -
Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales
26/08/2024 -
ClearPoint Neuro Announces Early Repayment of $10 Million Note
26/08/2024 -
PacBio to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
26/08/2024 -
Third Harmonic Bio to Participate in Upcoming Investor Conferences
26/08/2024 -
La Commission Européenne approuve BALVERSA®▼ (erdafitinib) chez les patients adultes atteints d’un carcinome urothélial non résécable ou métastatique
26/08/2024 -
Harvard Apparatus Regenerative Technology Announces $5 Million Financing to Continue Clinical Trial
26/08/2024 -
WORK Medical Technology Group LTD Announces Closing of Initial Public Offering
26/08/2024 -
AssureCare Welcomes Industry Leader Shane Powers as Vice President of Sales
26/08/2024 -
Genmab to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
26/08/2024
Pages